1. Staphylococcus aureus alpha toxin activates Notch in vascular cells
- Author
-
Stephanie Shen, Sonia L. Hernandez, Jared Emolo, Henry Biermann, Georgia R. Sampedro, Juliane Bubeck Wardenburg, Lydia Wu, Jessica J. Kandel, Bianca Lec, Naina Bagrodia, Mildred Nelson, Ann M. Defnet, and Rebecca Kirschner
- Subjects
0301 basic medicine ,Staphylococcus aureus ,Cancer Research ,Physiology ,Angiogenesis ,ADAM10 ,Bacterial Toxins ,Clinical Biochemistry ,Immunocytochemistry ,Notch signaling pathway ,Human leukocyte antigen ,Article ,ADAM10 Protein ,Hemolysin Proteins ,03 medical and health sciences ,0302 clinical medicine ,Bacterial Proteins ,Human Umbilical Vein Endothelial Cells ,Humans ,Staphylococcus aureus alpha toxin ,Receptors, Notch ,Chemistry ,Membrane Proteins ,Staphylococcal Infections ,Molecular biology ,Blot ,030104 developmental biology ,Notch proteins ,030220 oncology & carcinogenesis ,Amyloid Precursor Protein Secretases ,Signal Transduction - Abstract
Staphylococcus aureus infection is one of the leading causes of morbidity in hospitalized patients in the United States, an effect compounded by increasing antibiotic resistance. The secreted agent hemolysin alpha toxin (Hla) requires the receptor A Disintegrin And Metalloproteinase domain-containing protein 10 (ADAM10) to mediate its toxic effects. We hypothesized that these effects are in part regulated by Notch signaling, for which ADAM10 activation is essential. Notch proteins function in developmental and pathological angiogenesis via the modulation of key pathways in endothelial and perivascular cells. Thus, we hypothesized that Hla would activate Notch in vascular cells. Human umbilical vein endothelial cells were treated with recombinant Hla (rHla), Hla-H35L (genetically inactivated Hla), or Hank’s solution (HBSS), and probed by different methods. Luciferase assays showed that Hla (0.01 µg/mL) increased Notch activation by 1.75 ± 0.5-fold as compared to HBSS controls (p
- Published
- 2018
- Full Text
- View/download PDF